Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid, highly selective NaV1.8 pain signal inhibitor, suzetrigine, for the treatment of adults with moderate ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Micha Acopiado has been diagnosed with a stage 3 brain tumour after her partner noticed an odd symptom, as her work friends ...